AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Zaldiar Drug Insight Report 2019 - ResearchAndMarkets.com

November 29, 2019

DUBLIN--(BUSINESS WIRE)--Nov 29, 2019--

The “Zaldiar- Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s offering.

“Zaldiar Drug Insight, 2019” highlights the drug marketed details and the Global API Manufacturers details across the globe along with their location.

The report covers the Global Market Assessment of the Zaldiar covering the historical global sales and also provides the Zaldiar sales estimation during the forecasted period (2019-2021). The report also covers the patents information and market exclusivity data, route of synthesis, market competition, and API manufacturers by country.

In addition to this, the report also provides the SWOT analysis for Zaldiar and emerging therapies in this space.

Scope

Reasons to Buy

Key Topics Covered:

1. Report Introduction

2. Zaldiar- Overview

3. Product Details

4. Zaldiar Sales Assessment

5. Patent Details

6. Global API Manufacturers Assessment

7. Market Competition

8. Emerging Therapies

9. SWOT Analysis

For more information about this report visit https://www.researchandmarkets.com/r/lu8tvj

View source version on businesswire.com:https://www.businesswire.com/news/home/20191129005153/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 11/29/2019 05:00 AM/DISC: 11/29/2019 05:01 AM

http://www.businesswire.com/news/home/20191129005153/en